Mesenchymal stem cells and dental implant osseointegration during aging: from mechanisms to therapy

Stem Cell Res Ther. 2023 Dec 20;14(1):382. doi: 10.1186/s13287-023-03611-1.

Abstract

Dental implants are widely used to replace missing teeth, providing patients with unparalleled levels of effectiveness, convenience, and affordability. The biological basis for the clinical success of dental implants is osseointegration. Bone aging is a high-risk factor for the reduced osseointegration and survival rates of dental implants. In aged individuals, mesenchymal stem cells (MSCs) in the bone marrow show imbalanced differentiation with a reduction in osteogenesis and an increase in adipogenesis. This leads to impaired osseointegration and implant failure. This review focuses on the molecular mechanisms underlying the dysfunctional differentiation of aged MSCs, which primarily include autophagy, transcription factors, extracellular vesicle secretion, signaling pathways, epigenetic modifications, microRNAs, and oxidative stress. Furthermore, this review addresses the pathological changes in MSCs that affect osseointegration and discusses potential therapeutic interventions to enhance osseointegration by manipulating the mechanisms underlying MSC aging.

Keywords: Aging; Differentiation; Mesenchymal stem cells; Molecular mechanism; Osseointegration.

Publication types

  • Review

MeSH terms

  • Aged
  • Aging
  • Dental Implants*
  • Humans
  • Mesenchymal Stem Cells* / metabolism
  • Osseointegration
  • Osteogenesis / genetics
  • Surface Properties

Substances

  • Dental Implants